In Vitro Antiviral Activity of Sakuranetin against Human Rhinovirus 3.
10.24171/j.phrp.2017.8.6.09
- Author:
Hwa Jung CHOI
1
Author Information
1. Department of Beauty Science, Kwangju Women's University, Gwangju, Korea. rerived@empal.com
- Publication Type:Original Article
- Keywords:
sakuranetin;
human rhinovirus;
Sorbus commixta;
antiviral
- MeSH:
Adsorption;
Cervix Uteri;
Common Cold;
Female;
HeLa Cells;
Humans*;
In Vitro Techniques*;
Methods;
Rhinovirus*;
Ribavirin;
Sorbus
- From:
Osong Public Health and Research Perspectives
2017;8(6):415-420
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVES: Rhinoviruses (RVs) cause common cold and are associated with exacerbation of chronic inflammatory respiratory diseases. Until now, no clinically effective antiviral chemotherapeutic agents to treat diseases caused by human rhinoviruses (HRVs) have been reported. We assessed the anti-HRV3 activity of sakuranetin isolated from Sorbus commixta Hedl. in human epithelioid carcinoma cervix (HeLa) cells, to evaluate its anti-rhinoviral potential in the clinical setting. METHODS: Antiviral activity and cytotoxicity as well as the effect of sakuranetin on HRV3-induced cytopathic effects (CPEs) were evaluated using the sulforhodamine B (SRB) method using CPE reduction. The morphology of HRV3-infected cells was studied using a light microscope. RESULTS: Sakuranetin actively inhibited HRV3 replication and exhibited antiviral activity of more than 67% without cytotoxicity in HeLa cells, at 100 μg/mL. Ribavirin showed anti-HRV3 activity similar to that of sakuranetin. Treatment of HRV-infected HeLa cells with sakuranetin visibly reduced CPEs. CONCLUSION: The inhibition of HRV production by sakuranetin is mainly due to its general antioxidant activity through inhibition of viral adsorption. Therefore, the antiviral activity of sakuranetin should be further investigated to elucidate its mode of action and prevent HRV3-mediated diseases in pathological conditions.
